“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

However, his GP did not inform him about the drug's potential side effects, which include impulse control disorders such as ...

Dopamine agonists may be useful in depression associated (or not) with PD and pramipexole has been demonstrated to have the same efficacy of selective serotonin-reuptake inhibitors (SSRIs).

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

It’s spring and you’ve probably noticed a change in when the Sun rises and sets. But have you also noticed a change in your ...

GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...

Stevens was diagnosed with multiple sclerosis in 1995, and his condition deteriorated in 2015, prompting early retirement. In ...

An estimated one-quarter to one-third of people with schizophrenia have symptoms that don’t improve with traditional ...

Hello from San Diego, where I always happen to be, but where this weekend I had the delight of hanging out with coworkers ...

Headaches, nausea, dehydration: we all expect to feel a little worse for wear after a night of drinking. But for some of us, ...